SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-16-008387
Filing Date
2016-12-07
Accepted
2016-12-07 16:25:23
Documents
4
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM10-K ohrp-10ka_093015.htm 10-K/A 24487
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 3699
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 4555
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 4169
  Complete submission text file 0001387131-16-008387.txt   38120
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-35963 | Film No.: 162039329
SIC: 2834 Pharmaceutical Preparations